Lonza Group Ag Total Assets 2012-2019 | LZAGY

Lonza Group Ag total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Lonza Group Ag total assets for the quarter ending December 31, 2019 were $13.937B, a 43.1% increase year-over-year.
  • Lonza Group Ag total assets for 2017 were $14.015B, a 102.16% increase from 2016.
  • Lonza Group Ag total assets for 2016 were $6.932B, a 6.62% increase from 2015.
  • Lonza Group Ag total assets for 2015 were $6.502B, a 7.76% decline from 2014.
Lonza Group Ag Annual Total Assets
(Millions of US $)
2017 $14,015
2016 $6,932
2015 $6,502
2014 $7,048
2013 $7,061
2012 $7,576
2011 $7,949
Lonza Group Ag Quarterly Total Assets
(Millions of US $)
2019-12-31 $13,937
2018-12-31 $14,228
2018-06-30 $14,215
2017-12-31 $14,015
2017-06-30 $9,740
2016-12-31 $6,932
2016-06-30 $6,485
2015-12-31 $6,502
2015-06-30 $6,424
2014-12-31 $7,048
2014-06-30 $7,427
2013-12-31 $7,061
2013-06-30 $7,431
2012-12-31 $7,576
2012-06-30 $7,502
2011-12-31 $7,949
2011-06-30 $5,065
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $44.026B $0.978B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $175.389B 32.91
Medtronic (MDT) Ireland $135.096B 21.94
Stryker (SYK) United States $70.813B 27.46
Boston Scientific (BSX) United States $56.240B 32.49
Baxter (BAX) United States $41.987B 25.68
Terumo (TRUMY) Japan $29.409B 37.59
Zimmer Biomet Holdings (ZBH) United States $28.616B 23.75
EssilorLuxottica Societe Anonyme (ESLOY) France $28.260B 0.00
ResMed (RMD) United States $25.025B 36.34
Sunny Optical Technology (SNPTF) China $20.071B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $14.731B 66.62
Insulet (PODD) United States $13.054B 552.33
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.631B 51.02
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.229B 12.40
Hill-Rom Holdings (HRC) United States $6.398B 15.88
Canopy Growth (CGC) Canada $6.287B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.378B 0.00
Neogen (NEOG) United States $4.135B 69.09
Haemonetics (HAE) United States $4.050B 26.99
ICU Medical (ICUI) United States $4.048B 30.88
Envista Holdings (NVST) United States $3.688B 25.15
Abcam (ABCZY) $3.604B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.409B 0.00
National Vision Holdings (EYE) United States $2.831B 440.00
Agios Pharmaceuticals (AGIO) United States $2.792B 0.00
NuVasive (NUVA) United States $2.755B 38.40
DFB Healthcare Acquisitions (AHCO) United States $2.045B 188.38
TG Therapeutics (TGTX) United States $2.036B 0.00
AtriCure (ATRC) United States $1.843B 0.00
MacroGenics (MGNX) United States $1.447B 0.00
NanoString Technologies (NSTG) United States $1.356B 0.00
Aphria (APHA) Canada $1.281B 0.00
Aurora Cannabis (ACB) Canada $1.157B 0.00
Cerus (CERS) United States $1.138B 0.00
Cardiovascular Systems (CSII) United States $1.096B 0.00
InMode (INMD) Israel $0.995B 25.10
OraSure Technologies (OSUR) United States $0.960B 0.00
Quanterix (QTRX) United States $0.950B 0.00
Owens & Minor (OMI) United States $0.945B 21.17
Lantheus Holdings (LNTH) United States $0.914B 12.67
Omeros (OMER) United States $0.866B 0.00
PetIQ (PETQ) United States $0.832B 24.04
Phibro Animal Health (PAHC) United States $0.790B 15.76
Meridian Bioscience (VIVO) United States $0.750B 17.32
Vapotherm (VAPO) United States $0.742B 0.00
Surmodics (SRDX) United States $0.645B 70.73
VAREX IMAGING (VREX) United States $0.637B 15.81
BioLife Solutions (BLFS) United States $0.634B 330.33
Zynex (ZYXI) United States $0.623B 54.39
Eagle Pharmaceuticals (EGRX) United States $0.587B 82.92
LeMaitre Vascular (LMAT) United States $0.586B 35.79
Cytosorbents (CTSO) United States $0.401B 0.00
Viemed Healthcare (VMD) United States $0.399B 14.25
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.327B 0.00
Utah Medical Products (UTMD) $0.300B 25.71
InfuSystems Holdings (INFU) United States $0.258B 143.11
Organigram Holdings (OGI) Canada $0.234B 0.00
Female Health (VERU) United States $0.207B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Exagen (XGN) United States $0.181B 0.00
Bovie Medical (APYX) United States $0.178B 0.00
Fonar (FONR) United States $0.171B 15.14
Surface Oncology (SURF) United States $0.168B 0.00
Wound Management Technologies (SMTI) United States $0.167B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Evolus (EOLS) United States $0.126B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
Capricor Therapeutics (CAPR) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
United-Guardian (UG) United States $0.073B 16.35
Nephros (NEPH) United States $0.071B 0.00
Brainsway (BWAY) Israel $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00